Xuefu You

774 total citations
49 papers, 582 citations indexed

About

Xuefu You is a scholar working on Molecular Biology, Pharmacology and Molecular Medicine. According to data from OpenAlex, Xuefu You has authored 49 papers receiving a total of 582 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 18 papers in Pharmacology and 16 papers in Molecular Medicine. Recurrent topics in Xuefu You's work include Antibiotic Resistance in Bacteria (16 papers), Microbial Natural Products and Biosynthesis (10 papers) and Carbohydrate Chemistry and Synthesis (5 papers). Xuefu You is often cited by papers focused on Antibiotic Resistance in Bacteria (16 papers), Microbial Natural Products and Biosynthesis (10 papers) and Carbohydrate Chemistry and Synthesis (5 papers). Xuefu You collaborates with scholars based in China, Russia and Sweden. Xuefu You's co-authors include Xinxin Hu, Xinyi Yang, Yanxiang Wang, Tianyun Fan, Sheng Tang, Hao Wang, Wei Hong, Danqing Song, Xiukun Wang and Cheng‐Hang Sun and has published in prestigious journals such as PLoS ONE, Hepatology and Scientific Reports.

In The Last Decade

Xuefu You

44 papers receiving 578 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xuefu You China 16 251 171 147 83 69 49 582
Andrew Galgoci United States 7 240 1.0× 183 1.1× 101 0.7× 88 1.1× 37 0.5× 8 463
Maya Umekita Japan 14 253 1.0× 208 1.2× 120 0.8× 55 0.7× 25 0.4× 25 509
Matthieu Fonvielle France 19 579 2.3× 121 0.7× 189 1.3× 69 0.8× 56 0.8× 43 778
Gayathri Nagalingam Australia 16 302 1.2× 119 0.7× 150 1.0× 41 0.5× 114 1.7× 26 717
Feng Song China 16 541 2.2× 84 0.5× 124 0.8× 84 1.0× 30 0.4× 35 792
Fenglin Yin United States 10 577 2.3× 132 0.8× 131 0.9× 49 0.6× 38 0.6× 13 877
Cristina Brunati Italy 14 402 1.6× 357 2.1× 122 0.8× 54 0.7× 33 0.5× 30 657
Yanan Hu United States 11 682 2.7× 200 1.2× 392 2.7× 97 1.2× 39 0.6× 16 1.0k
Aaron J. Peoples United States 9 412 1.6× 213 1.2× 80 0.5× 74 0.9× 40 0.6× 15 592
Fabian Panter Germany 15 432 1.7× 343 2.0× 59 0.4× 45 0.5× 43 0.6× 24 654

Countries citing papers authored by Xuefu You

Since Specialization
Citations

This map shows the geographic impact of Xuefu You's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuefu You with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuefu You more than expected).

Fields of papers citing papers by Xuefu You

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuefu You. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuefu You. The network helps show where Xuefu You may publish in the future.

Co-authorship network of co-authors of Xuefu You

This figure shows the co-authorship network connecting the top 25 collaborators of Xuefu You. A scholar is included among the top collaborators of Xuefu You based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuefu You. Xuefu You is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Minghua, Ying Wang, Xiukun Wang, et al.. (2025). Novel Oxazolidinone Derivatives Containing Quaternary Ammonium Fragments with Potent Antibacterial Potency. ACS Medicinal Chemistry Letters. 16(9). 1780–1788.
2.
Ren, Yixin, Wenting Dong, Ying Zhou, et al.. (2024). The Prediction of LptA and LptC Protein–Protein Interactions and Virtual Screening for Potential Inhibitors. Molecules. 29(8). 1827–1827.
3.
Pang, Jing, Xixi Guo, Zhimeng Zhang, et al.. (2024). Discovery of Gambogic acid as an antibacterial adjuvant against vancomycin-resistant enterococci in vitro and in vivo. Phytomedicine. 128. 155400–155400. 4 indexed citations
4.
Yang, Xinyi, Congran Li, Xiukun Wang, et al.. (2024). An Update on the Clinical Pipelines of New Antibacterial Drugs Developed in China. Engineering. 38. 52–68. 5 indexed citations
7.
Sun, Cheng‐Hang, Dmitrii A. Lukianov, Ilya А. Osterman, et al.. (2020). Hetiamacin E and F, New Amicoumacin Antibiotics from Bacillus subtilis PJS Using MS/MS-Based Molecular Networking. Molecules. 25(19). 4446–4446. 15 indexed citations
8.
Wang, Hao, Meiling Chen, Xuefu You, et al.. (2020). Development of small molecule inhibitors targeting TGF-β ligand and receptor: Structures, mechanism, preclinical studies and clinical usage. European Journal of Medicinal Chemistry. 191. 112154–112154. 42 indexed citations
9.
Wu, Han, Yu Sun, Jiajia Cui, et al.. (2020). The development of a novel transforming growth factor-β (TGF-β) inhibitor that disrupts ligand-receptor interactions. European Journal of Medicinal Chemistry. 189. 112042–112042. 12 indexed citations
10.
Yang, Yan, Xue Li, Youwen Zhang, et al.. (2020). Characterization of a hypervirulent multidrug-resistant ST23 Klebsiella pneumoniae carrying a bla IncFII plasmid and a pK2044-like plasmid. Journal of Global Antimicrobial Resistance. 22. 674–679. 12 indexed citations
11.
Yang, Yan, Jian–Hua Liu, Xinxin Hu, et al.. (2020). Clinical and microbiological characteristics of hypervirulent Klebsiella pneumoniae (hvKp) in a hospital from North China. The Journal of Infection in Developing Countries. 14(6). 606–613. 16 indexed citations
12.
Wei, Wei, Xinxin Hu, Sheng Tang, et al.. (2019). Evolution and Antibacterial Evaluation of 8-Hydroxy-cycloberberine Derivatives as a Novel Family of Antibacterial Agents Against MRSA. Molecules. 24(5). 984–984. 10 indexed citations
13.
Li, Linli, Shufen Li, Bingya Jiang, et al.. (2019). Isarubrolones Containing a Pyridooxazinium Unit from Streptomyces as Autophagy Activators. Journal of Natural Products. 82(5). 1149–1154. 11 indexed citations
14.
Zhang, Dewu, Lili Zhao, Li‐Ning Wang, et al.. (2017). Griseofulvin Derivative and Indole Alkaloids from Penicillium griseofulvum CPCC 400528. Journal of Natural Products. 80(2). 371–376. 33 indexed citations
15.
Wang, Qiang, Yi-Xuan Zhang, Mian Wang, et al.. (2017). Neo-actinomycins A and B, natural actinomycins bearing the 5H-oxazolo[4,5-b]phenoxazine chromophore, from the marine-derived Streptomyces sp. IMB094. Scientific Reports. 7(1). 3591–3591. 44 indexed citations
16.
Liu, Shaowei, Xiaoyan Han, Zhong-Ke Jiang, et al.. (2016). Hetiamacin B–D, new members of amicoumacin group antibiotics isolated from Bacillus subtilis PJS. The Journal of Antibiotics. 69(10). 769–772. 22 indexed citations
17.
Jiang, Zhibo, Lei Xuan, Minghua Chen, et al.. (2016). Three structurally-related impurities in norvancomycin drug substance. The Journal of Antibiotics. 70(2). 158–165. 5 indexed citations
18.
Lü, Xi, Xinyi Yang, Yun Lu, et al.. (2013). In Vitro Activity of Sodium New Houttuyfonate Alone and in Combination with Oxacillin or Netilmicin against Methicillin-Resistant Staphylococcus aureus. PLoS ONE. 8(7). e68053–e68053. 35 indexed citations
19.
Liu, Shaowei, Jing Jin, Chuan Chen, et al.. (2013). PJS, a novel isocoumarin with hexahydropyrimidine ring from Bacillus subtilis PJS. The Journal of Antibiotics. 66(5). 281–284. 33 indexed citations
20.
Qin, Wei, Zhanying Hu, Junwei Tong, et al.. (2012). [Toxic effects of trimethadione on zebrafish early development].. PubMed. 34(9). 1165–73. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026